​

Akari Therapeutics Ownership | Who Owns Akari Therapeutics?

OverviewForecastFinancialsChart

Akari Therapeutics Ownership Summary

Akari Therapeutics is owned by 8.37% institutional investors, 15.55% insiders, and 76.08% retail investors. Sabby management is the largest institutional shareholder, holding 32.93% of AKTX shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.01% of its assets in Akari Therapeutics shares.

AKTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAkari Therapeutics8.37%15.55%76.08%
SectorHealthcare Stocks 246.48%12.12%-158.60%
IndustryBiotech Stocks 384.82%11.76%-296.58%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sabby management179.78K32.93%$210.33K
Newedge advisors6.80K1.25%$7.96K
Occidental asset management18.13K1.01%$168.56K
Eversource wealth advisors44.000.28%$44.00
Caitong asset management10.000.00%$93.00
Palo alto investors lp---
Truvestments capital---
Ifp advisors---
Cwa asset management group---
Jane street group---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sabby management179.78K0.38%$210.33K
Occidental asset management18.13K0.01%$168.56K
Ifp advisors---
Jane street group---
Truvestments capital---
Palo alto investors lp---
Omnia family wealth---
Hightower advisors---
Cwa asset management group---
Eversource wealth advisors44.00-$44.00

Top Buyers

HolderShares% AssetsChange
Sabby management179.78K0.38%179.78K
Occidental asset management18.13K0.01%18.13K
Newedge advisors6.80K-6.80K
Caitong asset management10.00-2.00
Morgan stanley---1.00

Top Sellers

HolderShares% AssetsChange
Cresset asset management---822.47K
Warberg asset management---308.34K
Palo alto investors lp---146.02K
Hightower advisors---79.24K
Jane street group---71.64K

New Positions

HolderShares% AssetsChangeValue
Sabby management179.78K0.38%179.78K$210.33K
Occidental asset management18.13K0.01%18.13K$168.56K
Newedge advisors6.80K-6.80K$7.96K

Sold Out

HolderChange
Morgan stanley-1.00
Cornerstone planning group-5.00
Truvestments capital-50.00
Sbi securities-200.00
Accent capital management-5.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20261066.67%149,980124.72%896551.13%7600.00%1-80.00%
Mar 31, 20263-85.71%7,256-99.84%-0.01%1-91.67%2-
Dec 31, 202514-12.50%683,594-41.58%209,2860.00%860.00%2-33.33%
Sep 30, 20251614.29%1,170,067112.45%7,43573.05%620.00%350.00%
Jun 30, 20251550.00%550,74080.99%10032469.88%5-3200.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index1.51K0.01%-
RiverNorth Marketplace Lending Corp1.10K0.00%-
RiverNorth Opportunities509.000.00%-
LUX IM Global Medtech HX1.00--

Recent Insider Transactions

DateNameRoleActivityValue
Dec 16, 2025Neal James R-Buy$960.27
Dec 16, 2025Neal James R-Buy-
Dec 16, 2025Neal James R-Buy$1.20K
Dec 16, 2025Neal James R-Buy-
Dec 16, 2025Prudo-Chlebosz Raymond-Buy-

Insider Transactions Trends

DateBuySell
2026 Q4--
2026 Q3--
2026 Q2--
2025 Q430-
2025 Q33-

AKTX Ownership FAQ

Who Owns Akari Therapeutics?

Akari Therapeutics shareholders are primarily institutional investors at 8.37%, followed by 15.55% insiders and 76.08% retail investors. The average institutional ownership in Akari Therapeutics's industry, Biotech Stocks , is 384.82%, which Akari Therapeutics falls below.

Who owns the most shares of Akari Therapeutics?

Akari Therapeutics’s largest shareholders are Sabby management (179.78K shares, 32.93%), Newedge advisors (6.8K shares, 1.25%), and Occidental asset management (18.12K shares, 1.01%). Together, they hold 35.19% of Akari Therapeutics’s total shares outstanding.

Does Blackrock own Akari Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Akari Therapeutics.

Who is Akari Therapeutics’s biggest shareholder by percentage of total assets invested?

Sabby management is Akari Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.38% of its assets in 179.78K Akari Therapeutics shares, valued at 210.33K$.

Who is the top mutual fund holder of Akari Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Akari Therapeutics shares, with 0.01% of its total shares outstanding invested in 1.51K Akari Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools